Total Payments
$1,566
2024 Payments
$261.44
Companies
21
Transactions
88
Medicare Patients
431
Medicare Billing
$26,481
Payment Breakdown by Category
Food & Beverage$1,504 (96.0%)
Education$61.88 (4.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,504 | 85 | 96.0% |
| Education | $61.88 | 3 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $222.20 | 13 | $0 (2024) |
| ABBVIE INC. | $204.55 | 13 | $0 (2022) |
| Merck Sharp & Dohme LLC | $168.46 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $144.30 | 7 | $0 (2024) |
| Minerva Surgical, Inc | $115.60 | 5 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $110.13 | 6 | $0 (2024) |
| Organon Llc | $103.00 | 6 | $0 (2024) |
| Myovant Sciences Inc. | $74.84 | 4 | $0 (2022) |
| Exeltis, USA Inc. | $71.26 | 4 | $0 (2022) |
| Medtronic, Inc. | $61.34 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261.44 | 13 | Astellas Pharma US Inc ($113.85) |
| 2023 | $377.43 | 17 | Sumitomo Pharma America, Inc. ($96.93) |
| 2022 | $268.00 | 14 | PFIZER INC. ($84.26) |
| 2021 | $194.05 | 11 | AbbVie Inc. ($64.74) |
| 2020 | $156.58 | 11 | PFIZER INC. ($41.08) |
| 2019 | $158.19 | 11 | AbbVie, Inc. ($60.50) |
| 2018 | $39.09 | 3 | Bayer HealthCare Pharmaceuticals Inc. ($13.46) |
| 2017 | $110.74 | 8 | Mission Pharmacal Company ($27.82) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Meditrina | — | Food and Beverage | Cash or cash equivalent | $15.15 | General |
| 11/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Biological | ||||||
| 09/23/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $23.77 | General |
| 09/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Biological | ||||||
| 09/11/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: ETONOGESTREL | ||||||
| 07/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Biological | ||||||
| 05/29/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: ETONOGESTREL | ||||||
| 04/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Biological | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: VACCINE | ||||||
| 04/03/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: HORMONE THERAPY | ||||||
| 02/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Biological | ||||||
| 02/06/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: ETONOGESTREL | ||||||
| 01/16/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: WOMENS HEALTH | ||||||
| 11/07/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: WOMENS HEALTH | ||||||
| 10/23/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: HORMONE THERAPY | ||||||
| 10/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Climara Pro (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Womens Health | ||||||
| 10/02/2023 | Hologic Sales and Service, LLC | NOVASURE (Device), FLUENT FLUID MANAGEMENT SYSTEM, MYOSURE TISSUE REMOVAL DEVICE | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Surgical | ||||||
| 08/29/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: HORMONE THERAPY | ||||||
| 08/28/2023 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: VACCINE | ||||||
| 08/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Biological | ||||||
| 06/07/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: HORMONE THERAPY | ||||||
| 05/15/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: ETONOGESTREL | ||||||
| 04/20/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: WOMENS HEALTH | ||||||
| 04/04/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: HORMONE THERAPY | ||||||
| 03/14/2023 | Minerva Surgical, Inc | — | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Ablation System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 20 | 29 | $5,365 | $1,620 |
| 2022 | 4 | 97 | 105 | $16,310 | $5,486 |
| 2021 | 5 | 156 | 184 | $30,227 | $10,395 |
| 2020 | 5 | 158 | 179 | $32,231 | $8,980 |
Total Patients
431
Total Services
497
Medicare Billing
$26,481
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 29 | $5,365 | $1,620 | 30.2% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 20 | 22 | $6,006 | $1,814 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 33 | $6,105 | $1,688 | 27.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 39 | 39 | $3,198 | $1,500 | 46.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,001 | $482.68 | 48.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 72 | $13,320 | $4,154 | 31.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 65 | 65 | $5,330 | $2,502 | 46.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 18 | $4,176 | $1,570 | 37.6% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 15 | 17 | $4,641 | $1,396 | 30.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,760 | $773.53 | 28.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 65 | $12,025 | $2,732 | 22.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 29 | $6,728 | $1,894 | 28.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 48 | 48 | $3,936 | $1,876 | 47.7% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 23 | 24 | $6,552 | $1,713 | 26.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 13 | 13 | $2,990 | $765.41 | 25.6% |
About Dr. Daniel Dwyer, MD
Dr. Daniel Dwyer, MD is a Obstetrics & Gynecology healthcare provider based in Nags Head, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467478230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Dwyer, MD has received a total of $1,566 in payments from pharmaceutical and medical device companies, with $261.44 received in 2024. These payments were reported across 88 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,504).
As a Medicare-enrolled provider, Dwyer has provided services to 431 Medicare beneficiaries, totaling 497 services with total Medicare billing of $26,481. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Nags Head, NC
- Active Since 07/14/2006
- Last Updated 01/04/2012
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1467478230
Products in Payments
- MYFEMBREE (Drug) $231.05
- PREMARIN (Drug) $176.12
- NEXPLANON (Drug) $150.60
- Veozah (Drug) $132.31
- LO LOESTRIN FE (Drug) $124.24
- Orilissa (Drug) $73.59
- SLYND (Drug) $71.26
- SONICISION (Device) $61.34
- CitraNatal (Drug) $52.57
- LILETTA (Drug) $36.21
- Endometrial Ablation System (Device) (Device) $31.56
- Kyleena (Drug) $30.76
- NUVARING (Drug) $27.10
- KEYTRUDA (Biological) $22.93
- Climara Pro (Drug) $20.73
- OVA1 (Device) $20.36
- GARDASIL (Biological) $20.23
- Paragard (Device) $17.24
- ANNOVERA (Drug) $16.03
- GARDASIL 9 (Biological) $15.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.